ArticleCurrent medical imaging2026
A Case Report of an Inflammatory Hepatocellular Adenoma Mimicking Hepatocellular Carcinoma in a Patient with Alcoholic Cirrhosis.
Article in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatocellular adenoma (HCA) is a benign liver tumor that can mimic hepatocellular carcinoma (HCC), especially in patients with cirrhosis. Inflammatory HCA, a subtype of HCA, is characterized by increased expression of inflammation-related proteins such as serum amyloid A (SAA). Distinguishing inflammatory HCA from other liver lesions, such as HCC, can be challenging on imaging, especially in cirrhotic livers. CASE PRESENTATION: A 44-year-old male with alcoholic liver cirrhosis was found to have a hepatic lesion in segment 8, which gradually increased in size from 15 mm to 43 mm over 47 months. The lesion exhibited arterial phase hyperenhancement and washout on delayed imaging. It fulfilled the Liver Imaging Reporting and Data System (LI-RADS) v2018 criteria for LR-5, indicating definite HCC. The patient underwent laparoscopic subsegmentectomy of segment 8 without prior biopsy. Histopathological examination confirmed the diagnosis of inflammatory HCA. Immunohistochemistry showed strong and diffuse expression of SAA and C-reactive protein, and no aberrant β-catenin expression. The lesion was initially diagnosed as HCC based on radiologic features; the final diagnosis was inflammatory HCA. The patient recovered well after surgery and was discharged nine days later.
conclusionInflammatory HCA can mimic HCC on imaging, especially in patients with alcoholic cirrhosis. In such cases, relying solely on imaging may lead to misdiagnosis. Correlation with clinical history, pathology, and immunohistochemical findings is important to avoid unnecessary surgery and ensure accurate diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.